Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients.
Business Model:
Revenue: $6
Employees: 11-50
Address: 12F rue Paul Vatine
City: Perigny
State: aquitaine
Zip: 17180
Country: FR
Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients. The company develops Valedia, a product that is in Phase II clinical trials for the treatment of type 2 diabetes.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2022 | Post-IPO Equity | $9.7M | 3/2016 | Seed Round | 1 | $2M |
Sofimac Investment Managers Sofimac Investment Managers |
11/2022 | Post-IPO Equity | $9.7M | 5/2021 | Post-IPO Debt | $1.5M |
Bpifrance |
4/2021 | Post-IPO Equity | $18M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|